HRT FINANCIAL LP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1475597 NEW YORK, NY

Position in HIMS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$5,908,752

+$4,562,352 QoQ

Shares Held

284,622

+227.0% QoQ

Ownership

0.123%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. HIMS ranks #3 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	66,842	$39,635,969
2	HLN	Haleon plc	1,100,190	$11,012,901
3	HIMS	Hims & Hers Health, Inc. This page	284,622	$5,908,752
4	TEVA	Teva Pharmaceutical Industries Ltd	140,222	$4,223,486
5	NBIX	Neurocrine Biosciences Inc	26,404	$3,478,462
6	LQDA	Liquidia Corp	86,687	$3,271,567
7	ALKS	Alkermes plc.	81,989	$2,899,131
8	TAK	Takeda Pharmaceutical Co Ltd	126,074	$2,334,890

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,908,752	284,622	+227.0%	Shares	Defined	2026-05-14
2024-03-31	$1,346,400	87,033	+23.1%	Shares	Defined	2024-05-13
2023-09-30	$444,728	70,704	-10.7%	Shares	Defined	2023-11-13
2023-06-30	$744,010	79,150	-53.3%	Shares	Defined	2023-08-11
2023-03-31	$1,681,033	169,459	+9.2%	Shares	Defined	2023-05-12
2022-12-31	$994,389	155,131	+743.5%	Shares	Defined	2023-02-10
2022-09-30	$102,627	18,392	-92.5%	Shares	Defined	2022-11-14
2022-06-30	$1,116,160	246,393	-67.2%	Shares	Defined	2022-08-12
2022-03-31	$4,005,676	751,534	+93.9%	Shares	Defined	2022-05-16
2021-12-31	$2,538,845	387,610	+314.0%	Shares	Defined	2022-02-14
2021-06-30	$1,019,467	93,615	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.